Aegis Capital Notes 'Uneventful' Q3 for Aerie Pharma (AERI); Rhopressa NDA Now Expected in Jan. '17

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. IBM
4. HCP
5. PI

6. BSX
7. LRCX
8. BA
9. BIIB
10. F

Aerie Pharma (AERI) Reports In-Line Q3 EPS

November 2, 2016 4:19 PM EDT

Aerie Pharma (NASDAQ: AERI) reported Q3 EPS of ($0.67), in-line with the analyst estimate of ($0.67).

For earnings history and earnings-related data on Aerie Pharma (AERI) click here.

... More